The BioGeneration Ventures team has been involved in building and developing early stage Life Sciences companies since 1996. Besides venture capital experience this experience includes fundraising, technology transfer, pre-clinical and clinical drug development, executive management, business development and out-licensing activities. As part of the active role of BioGeneration in its investments this experience is available to portfolio companies.

In addition BioGeneration has access to the experience and skills of Forbion Capital Partners that provides insight into most areas of drug discovery and development and a large international industrial, financial and scientific network.

Team Members:

Edward van Wezel

Wil Hazenberg